AbbVie Inc. Stock
€191.40
Your prediction
Description AbbVie
AbbVie (ABBV) is a publicly listed pharmaceuticals company headquartered in North Chicago, Illinois, United States. It was established in 2013 as a spinoff from Abbott Laboratories, and currently operates in more than 175 countries worldwide. The company has over 47,000 employees and specializes in research, development, and the commercialization of advanced therapies for a variety of diseases, including immunology, oncology, neuroscience, and virology.
ABBV's flagship product is Humira, which is used to treat a range of autoimmune conditions such as rheumatoid arthritis, psoriasis, Crohn's disease, and ulcerative colitis. Humira is one of the best-selling prescription drugs globally, generating over $19 billion in 2019.
In addition to Humira, AbbVie also has several other leading drugs in its product portfolio, including Imbruvica, which is used to treat B-cell malignancies like leukemia and lymphoma, and Skyrizi, which is used to treat psoriasis.
ABBV is listed on the New York Stock Exchange (NYSE) under the ticker symbol ABBV, and it is a constituent of the S 500 index. As of 2021, AbbVie has a market capitalization of over $180 billion, making it one of the largest pharmaceutical companies in the world.
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Not a member yet? Sign up for free!
Competitors of AbbVie
AbbVie's most important competitors in the pharmaceutical industry are:
1. Johnson Johnson (Symbol: JNJ)
2. Pfizer Inc. (Symbol: PFE)
3. Merck Co., Inc. (Symbol: MRK)
4. Roche Holding AG (Symbol: RHHBY)
5. Sanofi S.A. (Symbol: SNY)
These companies are all large multinational pharmaceutical companies with strong development pipelines, extensive product portfolios, and substantial global reach. They compete with AbbVie in areas such as immunology, oncology, virology, and neuroscience. In addition, they all have a significant presence in emerging markets, where they are competing to capture market share and grow their businesses. Competition in the pharmaceutical industry is intense, and these companies are continually striving to develop new and innovative drugs to stay ahead of their rivals.
Suppliers of AbbVie
AbbVie is a global biopharmaceutical company that focuses on discovering, developing, and delivering innovative medicines to patients. The company has a number of important suppliers that help it manufacture the drugs it develops, and ensure the quality and safety of its products. Here are some of the most important suppliers of AbbVie:
1. Raw materials suppliers: AbbVie sources raw materials such as chemical compounds, active pharmaceutical ingredients (APIs), excipients, and packaging materials from a wide range of suppliers around the world. These include large chemical and pharmaceutical companies, as well as smaller suppliers specialized in specific raw materials.
2. Contract manufacturers: AbbVie works with a number of contract manufacturers to produce its drugs on a large scale. These manufacturers operate facilities in the United States, Europe, and Asia, and are selected based on their expertise in specific manufacturing processes and their ability to meet AbbVie's quality standards.
3. Equipment and technology suppliers: AbbVie also relies on a variety of suppliers for equipment and technology used in its manufacturing processes. These include providers of specialized laboratory equipment, automated drug manufacturing systems, and software systems for tracking and documenting production processes.
4. Service providers: AbbVie works with a range of service providers to ensure the quality and safety of its products. These include companies that provide testing and analysis of raw materials and finished products, logistics and transportation services, and certification and compliance services.
Overall, AbbVie's suppliers play a critical role in the company's ability to develop and deliver innovative medicines to patients around the world. The company has established strong relationships with these suppliers to ensure the reliability and consistency of its supply chain, and continues to seek out new partners to support its ongoing research and development efforts.
Financial data and news for AbbVie
sharewise wants to provide you with the best news and tools for AbbVie, so we directly link to the best financial data sources.
Financials
News
AbbVie Call Options Spike 2,599%: Tracking the Big Bet
Unusual market activity is often the first sign that big changes are coming to a stock. Professional traders and large institutions frequently use the options market to place high-conviction
Healthcare Rotation Underway: 3 Stocks Leading the Charge
Is the artificial intelligence revolution hitting its first roadblock? For the first time since the AI boom began in 2023, the industry is starting to feel the weight of expectations, and many of
ABBV Stock: $250 May Be the New Floor After Big Q3 Earnings Beat
AbbVie Inc. (NYSE: ABBV) delivered a strong third-quarter earnings report with a beat on the top and bottom lines and an increase in its forward guidance. The results clear the way for ABBV stock
3 Pharmaceutical Growth Stocks to Buy and Hold for 10 Years
For many investors, getting involved with pharmaceutical stocks involves finding inexpensive stocks, often penny stocks, in hopes of investing in a breakthrough treatment for cancer, Alzheimer’s
3 Exceptional Stocks to Build Long-Term Wealth
With many stocks looking overvalued, many investors may be tempted to sell. However, there are several factors to consider before taking profits:
- Time horizon – when an investor will need the
Where Will AbbVie Be in 5 Years?
In some ways, AbbVie (NYSE: ABBV) isn't the same company it was five years ago. Sure, it's still in the biopharmaceuticals business. However, AbbVie has a new CEO. More importantly, it no longer
2 No-Brainer Dividend Stocks to Buy Hand Over Fist
Over the past decade, AbbVie (NYSE: ABBV) and Mastercard (NYSE: MA) have produced strong market returns. Their performance is even better once we account for dividends reinvested. That is one of the
Better Long-Term Buy: This Emerging Player or the Industry Leader?
AbbVie (NYSE: ABBV) is one of the largest pharmaceutical companies in the world. Though its portfolio spans many therapeutic areas, it is particularly well known for its work in immunology, a field
Why AbbVie Stock Trounced the Market in 2025
One of the better-quality companies in the pharmaceutical sector, AbbVie (NYSE: ABBV) had a phenomenal year in 2025. Bolstered by numerous positive developments, the company maintained its
2 High-Yielding Dividend Stocks That Retirees Can Rely on for Recurring Income
If you're a retiree, you may be concerned about how safe it is to invest in the stock market right now. Valuations are high, economic conditions are questionable, and it's getting more difficult to
The Best Healthcare Stocks to Buy With $5,000 in 2026 and Hold Forever
Healthcare-focused investors may be disappointed to learn that the sector underperformed the broader market last year. However, they might also appreciate the fact that there are plenty of stocks in
Could Buying This Stock Today Pay Off Big Over the Next 5 Years?
AbbVie (NYSE: ABBV) has delivered excellent returns over the past decade. It experienced a slight slowdown in recent years as it navigated the loss of patent exclusivity for its former best-selling
3 Absurdly Cheap Growth Stocks to Buy in 2026
If you want to set yourself up for good long-term returns, it's important to consider a stock's valuation. Even if you invest in great companies, if you're paying a massive premium for them, your
2 Healthcare Stocks That Can Diversify a Tech-Heavy Portfolio
The technology sector is an excellent place to find high-growth stocks with promising prospects. However, it is a cyclical sector that doesn't perform as well when the economy tanks. It's critical
Buying This Healthcare Stock Could Make You a Millionaire Retiree
Programs like Social Security aren't designed to replace workers' entire income once they reach retirement age. So, it's important for everyone to plan ahead and build a nest egg for their golden
Is AbbVie a Buy, Sell, or Hold in 2026?
While the healthcare sector has not kept pace with broader equities so far, some industry leaders have. AbbVie (NYSE: ABBV), a pharmaceutical giant, is one of them. The company's shares are up by
Is AbbVie a Millionaire Maker?
AbbVie (NYSE: ABBV) is an investment that is full of contradictions. It has a strong pharmaceutical business, but the third quarter of 2025 was terrible on the earnings front. It has an attractive
Worried About the Stock Market in 2026? These 3 Stocks Did Well During the Last Bear Market.
Is the S&P 500 due for a crash next year? That's a big question on the minds of many investors these days. Concerns about bubbles in tech and overall high valuations for the stock market have many
My Top 3 Healthcare Stocks to Buy in 2026
After trailing broader equities over the past few years, will the healthcare sector finally bounce back in 2026? It's hard to predict those things.
No matter what happens to the industry, though
Here Are 2 Affordable Healthcare Stocks to Buy Heading Into 2026
Looking for great stocks to be had at a bargain? Even though broader equities have performed well this year, there are companies, particularly in sectors that haven't kept up with the rest of the
Is AbbVie Stock Too Cheap to Ignore at Today's Price?
AbbVie (NYSE: ABBV), a pharmaceutical leader, has faced some challenges over the past three years. The company is managing some patent cliffs and clinical setbacks that worried investors and dinged
The Pharmaceutical Sector Is Surging. Here's 1 Stock Every Investor Should Have on Their Radar.
Pharmaceutical stocks have been on fire this year. The iShares U.S. Pharmaceuticals ETF (NYSEMKT: IHE), which tracks 43 drugmakers, is up almost 29% year to date and 11% over the past month.
There
Could Buying AbbVie Today Set You Up for Life?
One effective way to earn solid, long-term returns is to invest in dividend-paying stocks since reinvesting the payout can help boost stock performance. However, they aren't all created equal, and
3 High-Yielding Dividend Growth Stocks That Can Generate Passive Income for Your Portfolio for Years
Want some quality income-generating investments you can put in your portfolio for the long term, and not worry about? The stocks listed below check off those boxes and can make for ideal investments
AbbVie Stock Falls 4% -- What Investors Need to Know
Earnings season creates short-term winners and losers, companies whose shares rise or fall after they announce their quarterly updates. The good news is that among these short-term losers, there are